| [1] |
Sonata Jodele.Laurence Blavier.Janet M. Yoon.Modifying the soil to affect the seed：role of stromal－derived matrix metalloproteinase in cancer progression.Cancer Metastasis Rev, 2006, 25: 35-43.
|
| [2] |
Recent Developments in Patent Anti－Cancer Agents Targeting the Matrix Metalloproteinase(MMPs). Recent Patents on Anti－Cancer Drug Discovery, 2010, 6(33), 109-141.
|
| [3] |
Kahlenberg MS,Stoler DL,Basik M, et al.P53 tumor suppressor Gene status and the degree of genomic instability in sporadic Colorectal cancers.J Natl Cancer Inst, 1996, 88: 1665-1670.
|
| [4] |
Vihinen P,Kahari VM.Matrix metalloproteinase in cancer：Prognostic markers and therapeutic targets.Int J Cancer, 2002, 99(2): 157-166.
|
| [5] |
Kleiner DE,Stetler Stevenson WG.Matrix metalloproteinase and metastasis.Cancer Chemotherapy Pharmacology, 1999, 43: 42-51.
|
| [6] |
Sheu JR,Fong TH,Liu CM, et al.Expression of matrix metalloProteinase－9 in human Platelets：regulation of Platelet activation in vitro and in vivo studies.Br J PH armaeol, 2004, 143(l): 193-201.
|
| [7] |
Moran A,Iniesta P,Garcia C, et al.Clinical relevance of MMP－9, MMP2, TIMP21 and TIMP22 in colorectal cancer.Oncology Reports, 2005, 213: 115-120.
|
| [8] |
Heinke J,Kerber M.Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.Ontogeny, 2012, 31(24): 2919-2930.
|
| [9] |
Umadevi Damodharan,Ravikumar Ganesan,Uma C. Radhakrishnan.Expression of MMP2 and MMP9(Gelatinizes A and B)in Human Colon Cancer Cells.Appl Biochem Biotechnol, 2011, 165: 1245-1252.
|
| [10] |
Min Jung Kang,Sungae Jung,Ji Min Jung, et al.Associations between Single Nucleotide Polymorphisms of MMP2, VEGF, and HIF1A Genes and the Risk of Developing Colorectal Cancer.Anticancer research, 2011, 31: 575-584.
|
| [11] |
Ltkas JAC,Hawinkels,Kim, et al.VEGF release by MMP9..mediate heparin soleplate cleavage induces colorectal cancer angiogenesis.European Journal of Cancer, 2008, 44(13): 1904-1913.
|
| [12] |
Laurence Blavier,Janet M,Yves A, et al.DeClerck.Modifying the soil to affect the seed：role of stormily derived matrix metalloproteinase in cancer progression.Cancer Metastasis Rev, 2006, 25: 35-43.
|
| [13] |
Shapiro S,Khodalev O. Different activation forms of mmp2 oppositely affect the fate of endothelial cells.Am J Physiol Cell Physiol, 2010, 298(4): 942-951.
|
| [14] |
Thomas AC,Newby AC.Effects of matrix metalloproteinase－9 gene knock－out on vein graft remodeling in mice.J Vasc research, 2010, 47(4): 299-308.
|
| [15] |
Berditchevski F,Chang S,Bodorova J, et al.Generation of monoclonal antibodies to interim－associated proteins Evidence that α3β1 complexes with EMMPRIN/besieging/OX47/M6.J Biol Chem, 1997, 272: 29174-29180.
|
| [16] |
Guo H,Li R,Zucker S, et al.EMMPRIN(CD－147, an inducer of matrix metalloproteinase synthesis, also binds interstitial collagens to the tumor cells surface.Cancer Res, 2000, 60(4): 888-891.
|
| [17] |
Carr JB,Williams D,Richards M. Lateral deceits positioning for intramedullary nailing of the femur without the use of a fracture table.Orthopedics, 2009, 32(10): 721-724.
|
| [18] |
Dake Chu,Zhao Zhengwei,Yi Zhou.Matrix Metalloproteinase－9 is associated with relapse and prognosis of patients with colorectal cancer.Annals Surgical Oncology, 2012, 19: 318-325.
|
| [19] |
Dan Liu,Duan Wenyuan,Hong Guo, et al.Meta－analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinase and the risk of colorectal cancer.Int J Colorectal Dis, 2011, 26: 1099-1105.
|
| [20] |
Theret N,Musso O,Campion JP, et al.Over expression of matrix metalloproteiase－2 and tissue inhibitor of matrix metalloproteinase－2 in liver from patients with gastrointestinal adenocaicinoma and no detectable metastasis.Int J Cancer, 1997, 74(4): 426-432.
|
| [21] |
Zeng ZS,Huang Y,Cohen AM, et al.Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix MMP－9.J Clink Oncol, 1996, 14(12): 3133-3140.
|
| [22] |
Bendardaf R,Buhmeida A,Hilska M, et al.MMP－9(gelatinize B)expression is associated with disease－free survival and disease－specific survival in colorectal cancer patients.Cancer Invest, 2010, 28: 38-43.
|
| [23] |
Koumura H,Sugiyama Y,Kunieda K, et al.Significance in gene expression of matrix metalloproteinase－9, urokinase－type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colorectal cancer.Ganto Kagaku Ryoho, 1997, 24(2): 324-331.
|
| [24] |
Wei Dong,Hong Li,Zhang Yan, et al.Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.Acta Biochim Biophys Sin, 2011, 43: 840-848.
|
| [25] |
Moran A,Iniesta P,Garcia C, et al.Clinical relevance of MMP－9, MMP2, TIMP21 andTIMP22 in colorectal cancer.Oncology Reports, 2005, 213: 115-120.
|
| [26] |
Vesna V. Dragutinović, Nevena V, et al.Matrix metalloproteinase－2(MMP－2)and－9(MMP－9)in preoperative serum as independent prognostic markers in patients with colorectal cancer.Mol Cell Biochem, 2011, 355: 173-178.
|
| [27] |
Langers AM,Verspaget HW,Hawinkels LJ.MMP－2 and MMP－9 in normal mucosa are indep－endently associated with outcome of colorectal cancer patients.Br J Cancer, 2012, 106(9): 1495-1498.
|
| [28] |
Still K,Robson CN,Autzen P, et a1.Localization and quantification of mRNA for matrix metalloproteinase－2(MMP－2)and tissue inhibitor of matrix metalloproteinase－2(TIMP－2)inhuman benign and malignant prostatic tissue.Prostate, 2000, 42(1): 218-251.
|
| [29] |
Ara T,Kusafuka T,Inoue M, et a1.Determination of imbalance between MMP2 and TIMP－2 in human neuroblastoma by reverse transcription polymerase chain reaction and its correlation with tumor progression.J Pediatr Surg, 2000, 35(3): 4371-4377.
|
| [30] |
Holten Andersen L,Christensen IJ,Jensen SB, et a1.Saliva and plasma TIMP－1 in patients with colorectal cancer：a prospective study.SCAND J Gastroenterology , 2012, 47: 1234-1241.
|